Literature DB >> 21686799

A case for varicella vaccination in the immunosuppressed.

Michael Vaclav Holmes1, Sowsan F Atabani, Nasser Khan, Kate Steiner, Tanzina Haque, Gabrielle Slapak.   

Abstract

A middle-aged man with long-standing Crohn disease maintained in remission on low-dose immunosuppression presented with abdominal pain. Over the following few days he developed a vesicular rash, became dyspnoeic, confused and had two seizures. Despite high-dose intravenous aciclovir, he died. Disseminated varicella zoster virus, the cause of his death, could potentially have been prevented had he received varicella vaccination at an earlier stage.

Entities:  

Year:  2009        PMID： 21686799      PMCID： PMC3029559          DOI： 10.1136/bcr.07.2008.0461

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  15 in total

1.  Acyclovir prevents dissemination of varicella in immunocompromised children.

Authors:  G Nyerges; Z Meszner; E Gyarmati; S Kerpel-Fronius
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

2.  Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice.

Authors:  R A Santos; C C Hatfield; N L Cole; J A Padilla; J F Moffat; A M Arvin; W T Ruyechan; J Hay; C Grose
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

3.  Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data.

Authors:  J P Ioannidis; A C Collier; D A Cooper; L Corey; A P Fiddian; B G Gazzard; P D Griffiths; D G Contopoulos-Ioannidis; J Lau; A T Pavia; M S Saag; S L Spruance; M S Youle
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

4.  Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir.

Authors:  T Yagi; T Karasuno; T Hasegawa; M Yasumi; S Kawamoto; M Murakami; N Uosima; H Nakamura; A Hiraoka; T Masaoka
Journal:  Bone Marrow Transplant       Date:  2000-05       Impact factor: 5.483

5.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

6.  Decline in mortality due to varicella after implementation of varicella vaccination in the United States.

Authors:  Huong Q Nguyen; Aisha O Jumaan; Jane F Seward
Journal:  N Engl J Med       Date:  2005-02-03       Impact factor: 91.245

Review 7.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

8.  Infection with varicella-zoster virus after marrow transplantation.

Authors:  R M Locksley; N Flournoy; K M Sullivan; J D Meyers
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

Review 9.  Varicella-zoster virus: atypical presentations and unusual complications.

Authors:  John W Gnann
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

10.  Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain.

Authors:  R A Santos; J A Padilla; C Hatfield; C Grose
Journal:  Virology       Date:  1998-09-15       Impact factor: 3.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.